Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,086 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Catalytic lectin (leczyme) from bullfrog (Rana catesbeiana) eggs.
Nitta K, Ozaki K, Tsukamoto Y, Hosono M, Ogawakonno Y, Kawauchi H, Takayanagi Y, Tsuiki S, Hakomori S. Nitta K, et al. Among authors: tsukamoto y. Int J Oncol. 1996 Jul;9(1):19-23. doi: 10.3892/ijo.9.1.19. Int J Oncol. 1996. PMID: 21541475
Purification and some properties of ribonuclease from Xenopus laevis eggs.
Nitta K, Ozaki K, Hagioita K, Tsukamoto Y, Terasaki Y, Suzuki N, Sano A, Hosono M, Kawauchi H, Takayanagi Y. Nitta K, et al. Among authors: tsukamoto y. Biol Pharm Bull. 1993 Apr;16(4):353-6. doi: 10.1248/bpb.16.353. Biol Pharm Bull. 1993. PMID: 8358383 Free article.
Investigation of 5-FU disposition after oral administration of capecitabine, a triple-prodrug of 5-FU, using a physiologically based pharmacokinetic model in a human cancer xenograft model: comparison of the simulated 5-FU exposures in the tumour tissue between human and xenograft model.
Tsukamoto Y, Kato Y, Ura M, Horii I, Ishikawa T, Ishitsuka H, Sugiyama Y. Tsukamoto Y, et al. Biopharm Drug Dispos. 2001 Jan;22(1):1-14. doi: 10.1002/bdd.250. Biopharm Drug Dispos. 2001. PMID: 11745902
Effects of tolcapone, a catechol-O-methyltransferase inhibitor, on motor symptoms and pharmacokinetics of levodopa in patients with Parkinson's disease.
Yamamoto M, Yokochi M, Kuno S, Hattori Y, Tsukamoto Y, Narabayashi H, Tohgi H, Mizuno Y, Kowa H, Yanagisawa N, Kanazawa I. Yamamoto M, et al. Among authors: tsukamoto y. J Neural Transm (Vienna). 1997;104(2-3):229-36. doi: 10.1007/BF01273183. J Neural Transm (Vienna). 1997. PMID: 9203084 Clinical Trial.
1,086 results